Physician profile
Connie Pham
NPI 1073967584
$2,214.35
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $19.09 · 2021: $124 · 2022: $335 · 2023: $685 · 2024: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $523.33 | 2019-2024 | Breztri, Airsupra, Farxiga |
| Teva Pharmaceuticals USA, INC. | $266.93 | 2019 | |
| Glaxosmithkline, LLC. | $207.18 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $170.03 | 2021-2024 | Prolia, Evenity |
| Abbvie INC. | $155.98 | 2022-2024 | |
| Pfizer INC. | $140.60 | 2022-2024 | |
| Novo Nordisk INC | $134.12 | 2022-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $117.20 | 2022-2023 | Mounjaro, Emgality, Jardiance |
| Otsuka America Pharmaceutical, INC. | $102.49 | 2022-2023 | Rexulti, Abilify Maintena |
| Abbott Laboratories | $70.94 | 2023-2024 | Freestyle Libre 2, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.57 | 2022-2023 | Jardiance, Tradjenta |
| Shield Therapeutics INC | $65.46 | 2023-2024 | Accrufer |
| Exact Sciences Corporation | $63.78 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $47.25 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $37.62 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microtransponder, INC. | $24.78 | 2024 | |
| Horizon Therapeutics Plc | $19.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.